.Pharmacolibrary.Drugs.R_RespiratorySystem.R03A_AdrenergicsInhalants.R03AC02_Salbutamol.Salbutamol_1

Information

Salbutamol (albuterol) - short-acting beta-2 adrenergic agonist for acute asthma and COPD; approved standard treatment.

Pharmacokinetics

Pharmacokinetic parameters for healthy male volunteers after intravenous bolus administration.

References

1. Vet, NJ, et al., & de Hoog, M (2020). Population Pharmacokinetics of Intravenous Salbutamol in Children with Refractory Status Asthmaticus. Clinical pharmacokinetics 59(2) 257–264. DOI:10.1007/s40262-019-00811-y PUBMED:https://pubmed.ncbi.nlm.nih.gov/31432470

2. Marques, L, & Vale, N (2024). Improving Individualized Salbutamol Treatment: A Population Pharmacokinetic Model for Oral Salbutamol in Virtual Patients. Pharmaceutics 17(1) –. DOI:10.3390/pharmaceutics17010039 PUBMED:https://pubmed.ncbi.nlm.nih.gov/39861686

3. Antoniu, S (2014). Bedoradrine for treating asthma and chronic obstructive pulmonary disease. Expert opinion on investigational drugs 23(8) 1149–1156. DOI:10.1517/13543784.2014.928284 PUBMED:https://pubmed.ncbi.nlm.nih.gov/24938936

Revisions

• 06/2025 initial generated model